作者: Joel D. Meyers , James C. Wade , Charles D. Mitchell , Rein Saral , Paul S. Lietman
DOI: 10.1016/0002-9343(82)90097-3
关键词: Viral shedding 、 Mucocutaneous zone 、 Immunology 、 Host (biology) 、 Medicine 、 Herpes simplex virus infection 、 Virology
摘要: Abstract Intravenous acyclovir was evaluated in the treatment of 97 immunocompromised patients with mucocutaneous herpes simplex virus infection a randomized, double-blind, placebo-controlled trial. Acyclovir recipients had significantly shorter periods shedding (p